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Managing Concurrent Discitis and Epidural Abscess Following TFESI Arising from
Unlikely Bacterial Species: The Importance of Post-Procedure Education
Abstract
Introduction::
Transforaminal epidural steroid injection (TFESI) can provide pain relief when patients’ radicular pain is
refractory to medication and physical therapy. However, it is important that clinicians understand potential
signs and symptoms of TFESI complications to prevent long-term sequelae. Literature has not
documented both discitis and an epidural abscess concurrently following a lumbar TFESI.
Case:
We present a patient with stage 3c melanoma on the right lower extremity (RLE) with worsening lower
extremity and foot pain. The pain was refractory to his current medication regimen of Gabapentin, and he
wanted an alternative to opioids. A right L2-L5 TFESI was performed and his pain improved, however, at
nine days post-operation, the patient presented with left paraspinal back pain that migrated to the right.
He was found to have a leukocytosis and blood cultures revealed Group G streptococcus. MRI of the
lumbar spine showed L1-L2 discitis with a left-sided epidural abscess. After an 8-week course of
ceftriaxone his follow-up MRI showed resolution of his acute disease.
Discussion:
This is a rare case showing concurrent discitis and epidural abscess after right L2-L5 TFESI likely
secondary to cellulitis in the setting of melanoma. Additionally, the Group G streptococci bacterial
etiology is unique compared to other reports of discitis given that Staphylococcus aureus is the most
common species. Understanding the signs, symptoms, and presentations of these infections is vital for
all specialties of physicians. Educating patients regarding the appropriate return precautions after back
procedures can help patients present in a timely manner to prevent long-term sequelae.
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Abstract
Introduction: Transforaminal epidural steroid injection (TFESI) can provide pain relief when patients’ radicular pain is
refractory to medication and physical therapy. However, it is important that clinicians understand potential signs and
symptoms of TFESI complications to prevent long-term sequelae. Literature has not documented both discitis and an
epidural abscess concurrently following a lumbar TFESI.
Case: We present a patient with stage 3c melanoma on the right lower extremity (RLE) with worsening lower extremity
and foot pain. The pain was refractory to his current medication regimen of Gabapentin, and he wanted an alternative to
opioids. A right L2-L5 TFESI was performed and his pain improved, however, at nine days post-operation, the patient
presented with left paraspinal back pain that migrated to the right. He was found to have a leukocytosis and blood
cultures revealed Group G streptococcus. MRI of the lumbar spine showed L1-L2 discitis with a left-sided epidural
abscess. After an 8-week course of ceftriaxone his follow-up MRI showed resolution of his acute disease.
Discussion: This is a rare case showing concurrent discitis and epidural abscess after right L2-L5 TFESI likely secondary to
cellulitis in the setting of melanoma. Additionally, the Group G streptococci bacterial etiology is unique compared to other
reports of discitis given that Staphylococcus aureus is the most common species. Understanding the signs, symptoms, and
presentations of these infections is vital for all specialties of physicians. Educating patients regarding the appropriate return
precautions after back procedures can help patients present in a timely manner to prevent long-term sequelae.
Keywords: Discitis, Epidural abscess, Transforaminal epidural steroid injection, Group G streptococcus

1. Introduction

T

he incidence and prevalence of chronic pain
continues to be an issue that negatively impacts the functionality of adults throughout the
world. Researchers estimate 20% of adults globally
suffer from chronic pain and 10% are newly diagnosed each year.1 The prevalence and treatment
difﬁculties contribute to America's ongoing massive
opioid epidemic with over 42,000 deaths secondary
to opioid overdose annually.2 The creation of this
epidemic was multimodal and adequately addressing chronic pain syndrome has led to an increase in

the use of interventional techniques to treat pain. A
transforaminal epidural steroid injection (TFESI)
can provide short and long term relief for chronic
radicular pain.3 In some cases with neuropathic pain
where spinal cord stimulator is being considered, an
epidural steroid injection can be used as a predictor
of success for the stimulator.4 However, it is
important that clinicians understand the potential
risks of introducing a needle that provides the
analgesic to the epidural space. Appropriate patient
education of the signs and symptoms of infection is
vital to prevent permanent neurologic damage from
taking place.
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We present a case of a patient with multiple
comorbidities who developed discitis and an epidural
abscess concurrently following a lumbar TFESI secondary to Group G streptococcus. This retrospective
case study aims to present the risk factors, diagnostic
(clinical and radiographical) features and management of discitis and epidural abscesses.

2. Case
A 60-year-old male with a past medical history of
stage 3c metastatic melanoma to the right lower
extremity (RLE) presented with progressively
worsening stabbing right groin, hip, lower extremity, and foot pain. The pain was worse while
standing, walking, and bending forward and was
relieved by lying prone or laterally. Review of systems was negative for fever, chills, and dysuria.
Upon examination, his RLE had dermal melanoma
lesions painful to palpation encompassing the L2 to
S1 dermatomes. Lymphedema and mild erythema
were present on the lower extremity but without
any signs of infection. Strength was 5/5 in lower
extremities. A Positive Emission TomographyComputed Tomography showed progression of the
disease, and the patient's pain was refractory to his
current medication regimen of Gabapentin 600 mg
TID. He was reluctant to escalate his pain regiment
to include opioids. After discussing the risks and
beneﬁts, a right L2-L5 lumbar TFESI using 5 mg
dexamethasone with 1.5 ml 0.25% bupivacaine at
each level was performed to address his painful
dermatomes. His post procedure pain was 0/10.
Subsequently, our plan was to consider a spinal
cord stimulator if received beneﬁt from the epidural
waned.
At nine days post-op, the patient reported 80%
pain relief for three days before the pain returned to
baseline. Additionally, on exam, there was crusting
and weeping of the melanoma lesions across the
lower extremity without signs of active infection,
however, the patient denied any fever or chills over
this period. He was also seen by his oncologist who
noticed worsening lymphedema and new neck and
axillary lesions prompting a change in immunotherapy from pembrolizumab to ipilimumab. He
received this immunotherapy infusion on the tenth
day. On the eleventh day, he presented to the
emergency department with a chief complaint of
feeling tired and persistent back pain. He reported
taking a nap due to his fatigue, and when he awoke,
he could not move his legs for 4 h. Initially his back
pain was left sided but over time it migrated to the
right midback with radiation to the right upper
quadrant of his abdomen. Upon exam, he was found
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to have severe bilateral paraspinal muscle tenderness. His neurologic and motor strength exam
remained intact.
The patient was admitted, and a complete blood
count and comprehensive metabolic panel showed a
leukocytosis with white blood cell count (WBC)
8.2  103/mcL, prior to his immunotherapy infusion,
to 17.6  103/mcL. Blood cultures were sent, and
gram stain revealed gram positive cocci and later
the culture grew Group G streptococcus. Computed
Tomography Abdomen and Pelvis was unrevealing,
however, an Magnetic Resonance Imaging (MRI) of
lumbar spine with and without contrast showed
epidural enhancement surrounding the L1-L2 disc
space and a ﬂuid signal collection that measured
6.0  7.0  18 mm (anteroposterior vs transverse vs
craniocaudal) on the left ventral surface of the thecal
sac (Fig. 1). These ﬁndings were concerning for
discitis and an epidural abscess. Neurosurgery did
not recommend intervention given the small size of
abscess. The infectious disease team was consulted
and recommended an 8-week course of ceftriaxone,
and he was discharged with the appropriate pain
management for his symptoms. Subsequently, 45
days later, he underwent another MRI that showed
resolution of the epidural enhancement and the
small ﬂuid collection (Fig. 2).

3. Discussion
While discitis and epidural abscesses are a rare
adverse outcome of a TFESI, it is important that
clinicians understand the anatomy and comorbidities that can lead to these. Anatomically, discitis
and epidural abscesses most often occur because of
hematogenous spread via the Batson vertebral

Fig. 1. Initial lumbar spine MRI with contrast in the axial plane
depicting both the discitis (red) and the epidural abscess (blue).
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Fig. 2. Lumbar spine MRI with contrast in the axial plane 45 days later
depicting improved epidural enhancement and resolution of the epidural
abscess.

plexus as well as arterial spread via the anterior and
posterior spinal arteries. The most common comorbidity for both diagnoses is diabetes.5,6 Both also
have many of the same predisposing factors such as
immunocompromised status, intravenous drug
abuse, kidney failure, spinal surgery, and foreign
bodies.5,6 As in our case, the classic presentation of
many of these patients is localized tenderness and
restricted mobility. A percentage of patients will
also experience motor, sensory, and reﬂex neurologic deﬁcits. These are typically emergent cases
that cannot be missed.5 It is also important to note
that only 50% of patients with epidural abscesses
will have fever, only 45% will have an elevated WBC
count, and biopsies only yield positive cultures in
50% of cases.5
Additionally, the most common cause of discitis
is Staphylococcus aureus.6 However, our case is
unique compared to other reports of discitis in that
Group G streptococcus is the bacterial etiology
rather than a staphylococcal species.6 Group G
streptococcus is typically found in skin ﬂora and
supports this patient's infectious etiology being
epidermis breakdown secondary to melanoma
disease in the setting of TFESI. An underlying
systemic infection is the most common etiology for
discitis.7 Our patient's crusting melanoma wound
may have seeded this infection. Even though our
patient did not have his skin lesion close to the site
of injection, it is important to take note of any potential source of infection in patients undergoing
these elective procedures and explain that it may
cause them to be at a higher risk of an adverse
event.
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Of note, steroids are associated with increased
rates of infectious complications.8 Considering that
epidural steroid injections can reach systemic circulation, this is an important risk factor to explain to
patients.9e11 One trial using triamcinolone acetonide 80 mg epidural steroid injections demonstrated
a maximum serum concentration of 5.5 ± 2.2 ng/mL
with a time to maximum concentration of 37.5 ± 37.7
hours and an elimination half-life of 506 ± 255
hours.9 On the other hand, a trial using methylprednisolone acetate 80 mg epidural steroids injections had no systemic absorption.10 Current
evidence suggests that less water-soluble forms of
glucocorticoids, such as methylprednisolone, are
more likely to be stored in epidural fat.11 Given that
steroids can remain in the epidural space and
decrease immune responses, TFESI may have
facilitated the infection in this case. Unfortunately,
no studies have been done on the pharmacokinetics
of epidural steroid injections for dexamethasone.
When infection is suspected and an abnormal
neurologic exam is present, a stat MRI and broadspectrum antibiotics should be ordered along with
an appropriate work-up. This coverage can be narrowed once sensitivities are obtained. However, if
the patient is stable, blood cultures and biopsies
should be drawn before beginning antibiotic therapy. Patients with cervical or thoracic pathology
should receive more aggressive treatment. A worsening neurologic exam is an indication for Spine
Surgery consultation.12

4. Conclusion
This is the ﬁrst case to show concurrent discitis
and epidural abscess after TFESI secondary to
cellulitis in the setting of stage 3c melanoma.
Additionally, this case is unique compared to other
reports of discitis in that Group G streptococci is the
bacterial etiology of this infection rather than
staphylococcus. The identiﬁed risk factors can aid
practitioners when an infection is suspected,
particularly in the setting of skin breakdown.
Moreover, less water-soluble steroids can remain in
the epidural space and facilitate infectious processes. Providers should note any potential source
of infection, even if remote from the injection site,
and advise patients accordingly.
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